Transcatheter Aortic Valve Replacement
"Transcatheter Aortic Valve Replacement" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical treatment for severe AORTIC VALVE STENOSIS. Transcatheter aortic valve replacement (TAVR) is used as an alternative option in patients who are deemed at high risk or inoperable for traditional open-heart surgery.
Descriptor ID |
D065467
|
MeSH Number(s) |
E04.100.376.485.500 E04.650.410.500 E04.928.220.410.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Transcatheter Aortic Valve Replacement".
Below are MeSH descriptors whose meaning is more specific than "Transcatheter Aortic Valve Replacement".
This graph shows the total number of publications written about "Transcatheter Aortic Valve Replacement" by people in this website by year, and whether "Transcatheter Aortic Valve Replacement" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 2 | 0 | 2 |
2015 | 5 | 1 | 6 |
2016 | 8 | 0 | 8 |
2017 | 6 | 2 | 8 |
2018 | 9 | 0 | 9 |
2019 | 14 | 1 | 15 |
2020 | 21 | 1 | 22 |
2021 | 20 | 1 | 21 |
2022 | 24 | 0 | 24 |
2023 | 14 | 0 | 14 |
2024 | 15 | 1 | 16 |
2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Transcatheter Aortic Valve Replacement" by people in Profiles.
-
Cerebral Air Embolism Risks in TAVR Procedures: Insights from a 75-Year-Old Patient Case. Am J Case Rep. 2025 Jan 30; 26:e946254.
-
Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions. Int J Cardiol. 2025 Mar 01; 422:132946.
-
Meta-analysis of longitudinal comparison of transcatheter versus surgical aortic valve replacement in patients at low to intermediate surgical risk. Int J Surg. 2024 Dec 01; 110(12):8097-8106.
-
Contemporary Outcomes of TAVR Using a Balloon-Expandable Valve in Patients With Severe Mitral Stenosis: Insights From the Transcatheter Valve Therapies Registry. Circ Cardiovasc Interv. 2024 Dec; 17(12):e014216.
-
Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation. JACC Cardiovasc Interv. 2025 Jan 13; 18(1):44-57.
-
Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials. J Am Heart Assoc. 2024 Nov 05; 13(21):e036179.
-
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients. Circ Cardiovasc Interv. 2024 Nov; 17(11):e014018.
-
Association of Baseline Tricuspid Regurgitation With Health Status and?Clinical Outcomes After TAVR?and?Mitral TEER. JACC Cardiovasc Interv. 2024 Aug 26; 17(16):1905-1915.
-
Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement. Expert Rev Cardiovasc Ther. 2024 Aug; 22(8):409-420.
-
Sutureless Valves, a "Wireless" Option for Patients With Aortic Valve Disease: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Jul 23; 84(4):382-407.